πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda β€” grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≀24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β€” use filters for patent-cliff planning.

Page 4 of 30

  1. US 11702419

    Heterocyclic compound and use thereof

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11701421

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11696893

    Preparation comprising vonoprazan

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11690839

    Treatment of idiopathic pulmonary fibrosis

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11685780

    Single domain antigen binding domains that bind human Trop2

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11684632

    Maribavir isomers, compositions, methods of making and methods of using

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11672831

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11670409

    Method and apparatus for providing a pharmacokinetic drug dosing regiment

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11666594

    Antibody-drug conjugates comprising a cyclic dinucleotide

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11660328

    GLP-2 analogs and peptibodies for administration before, during or after surgery

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11660318

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11661593

    Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11655241

    Heterocyclic compound and use thereof

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11648304

    Zika vaccines and immunogenic compositions, and methods of using the same

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11649206

    Method for producing pyrrole compound

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11613586

    Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11603519

    T-cell receptor

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11596671

    Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11596688

    Predicting outcome of treatment with an anti-Ξ±4Ξ²7 integrin antibody

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11597928

    Nucleic acid complex

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11590221

    Dengue vaccine unit dose and administration thereof

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11584737

    Heterocyclic compound

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11583526

    Treatment of prostate cancer

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11583563

    Adeno-associated virus formulations

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11576863

    Formulation of an antibody and use thereof

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11571466

    Compositions and methods for treating Gaucher disease

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11564979

    Stabilized liquid and lyophilized ADAMTS13 formulations

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11564992

    Nucleophilic catalysts for oxime linkage

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11560372

    Heterocyclic compounds useful as modulators of acetylcholine receptors

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11530393

    Compositions comprising iduronate-2-sulfatase

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11529363

    Methods of treating cancer in pediatric patients

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11529395

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11512066

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11505620

    Methods of detecting plasma kallikrein

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11492388

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11478541

    Method for inactivating Zika virus and for determining the completeness of inactivation

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11478511

    Lymphocyte biomarkers for determining the clinical response to cell therapy

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11464869

    Non-adult human dosing of brentuximab vedotin

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11465994

    MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11464815

    Dengue vaccine unit dose and administration thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11459325

    Heterocyclic compound

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11453661

    Heterocyclic compound

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11447488

    Heterocyclic compounds

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11440883

    Heterocyclic compound and use thereof

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11434304

    Anti-CD38 antibodies

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11433029

    Formulation of an antibody and use thereof

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11426397

    Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11426461

    Methods for preventing dengue and hepatitis A

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.